BioLeaders

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
BioLeaders group is a global healthcare group striving to provide high quality of life for all people. From molecular diagnostics, health functional foods, cosmeceuticals, to new drug development, BioLeaders group is following its mission in providing 'Excellence in Everyday Healthcare.' BioLeaders corporation takes responsibility of new drug development from the healthcare group. With its two patented proprietary platform technologies, BioLeaders is conducting three separate clinical trials (Phase 3, 2b, and 1) in South Korea and plans to move abroad. BioLeaders also have licensed-in a mutated p53 reactivating technology from the Weizmann Institute of Science, in Israel, and established a joint venture in proceeding with the development of the technology.
Ticker:
142760
Exchange:
Korea stock exchange (KOSDAQ)
Company Type:
Not Provided
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
CIN treatment, DMD treatment
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director
BioLeaders